China National Pharmaceutical Investment Overview

  • Investor Type
  • PE/​Buyout

  • Status
  • Active

  • Professionals
  • 3

Professionals

  • Investments
  • 13

  • Portfolio
  • 9

  • Exits
  • 3

Exits

China National Pharmaceutical Investment General Information

Company Description

Founded in 1964, China National Pharmaceutical Investment is a private equity firm based in Beijing, China. The firm seeks to invest in strategic emerging, pharmaceuticals, biotechnology, surgical devices, medical supplies, and healthcare sectors.

Business Details

Formerly Known As
China Pharmaceutical Industry Corporation
Year Founded
1964
Investor Status
Actively Seeking New Investments
Primary Investor Type
PE/Buyout
Other Investor Types
Accelerator/Incubator
Government
Corporate Office
  • Building 3, Number 6 Yuanda South Street
  • Haidian District
  • Beijing, 100097
  • China
+86 010

China National Pharmaceutical Investment Investments & Acquisitions (13)

China National Pharmaceutical Investment’s most recent investment was a with Xishan Science & Technology for . The deal was made on 13-Dec-2021.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Xishan Science & Technology 13-Dec-2021 Surgical Devices Profitable
Linuo Glass 11-Nov-2021 Medical Supplies Profitable
Innostar 01-May-2021 Other Pharmaceuticals and Biotechnology Profitable
King-eagle Med 09-Apr-2021 BPO/Outsource Services Profitable
Maxim Biotechnologies 15-Jun-2020 Merger/Acquisition Diagnostic Equipment Generating Revenue
You’re viewing 5 of 13 investments and acquisitions. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

China National Pharmaceutical Investment Exits (3)

China National Pharmaceutical Investment has made a total of 3 exits. Its latest exit was from Innostar for on 03-Sep-2024. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size
Innostar 03-Sep-2024
Xishan Science & Technology 06-Jun-2023
Haier BioMedical 25-Oct-2019 IPO
To view China National Pharmaceutical Investment’s complete exits history, request access »

China National Pharmaceutical Investment Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

China National Pharmaceutical Investment FAQs

  • What is China National Pharmaceutical Investment?

    Founded in 1964, China National Pharmaceutical Investment is a private equity firm based in Beijing, China.

  • When was China National Pharmaceutical Investment founded?

    China National Pharmaceutical Investment was founded in 1964.

  • Where is China National Pharmaceutical Investment headquartered?

    China National Pharmaceutical Investment is headquartered in Beijing, China.

  • How many investments has China National Pharmaceutical Investment made?

    China National Pharmaceutical Investment has made 13 investments.

  • What has China National Pharmaceutical Investment invested in?

    China National Pharmaceutical Investment has made numerous investments in companies like Xishan Science & Technology, Linuo Glass, and Innostar within the Surgical Devices, Medical Supplies, and Pharmaceuticals and Biotechnology industries.

  • What has China National Pharmaceutical Investment invested in recently?

    China National Pharmaceutical Investment's latest investment was on 13-Dec-2021 in Xishan Science & Technology, a company within the Surgical Devices industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process